News
As the market gets set for its next explosive run, four cryptocurrencies will be at the top of the list of market analysts ...
The SEC postpones its verdict on Grayscale’s Litecoin ETF bid, adding to delays as crypto ETF competition intensifies amid ...
Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging ...
4d
Week99er on MSNCardano Could Pump 300% To New Highs in August, But Unilabs & Litecoin Dominate Utility ChartsCardano is looking to surge by 300% in August. A rally that could see the SOL token hit a new ATH. However, Unilabs and ...
GSR announced an investment and strategic partnership with MEI Pharma in which it will serve as both strategic advisor and digital asset treasury manager.
Attention remains on large-cap tokens on Friday as crypto bills’ approval fueled crypto rallies. While Ethereum steadied above $3,600, Litecoin surpassed the $100 psychological zone. LTC gained more ...
MEI Pharma has become the first publicly traded company to adopt Litecoin (LTC) as a primary treasury reserve asset.
CoinGlass derivatives data show that the Open Interest (OI) for LTC has increased by 9.52% over the last 24 hours, reaching $746.84 million. An increasing OI represents new or additional money ...
After months of behind-the-scenes action, Litecoin, Bitcoin’s little sister, might be ready to make a major splash. Litecoin ...
Institutional investment has been the issue on many investors’ minds this year, especially given the approval of spot ETFs for both Bitcoin and Ether. The question floating around has been which ...
Litecoin Price Forecast: LTC reclaims $100 as NASDAQ-listed MEI Pharma unveils $100 million treasury
Litecoin (LTC) price extends its recovery, trading at around $104 on Friday, after breaking above $100 for the first time in nearly two months. Institutional demand for LTC is increasing, reflected by ...
A little-known Nasdaq-listed drugmaker plans to invest $100M in litecoin, appoints Charlie Lee to its board and names GSR as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results